A high level of expression of RNF126 in early breast cancer patients without lymph node metastases may indicate a high-risk type of metastatic disease, possibly due to RNF126, which may increase breast cancer cell proliferation and invasion. Here, RNF126 is linked to metastatic malignant neoplasm in the lymph nodes.